SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3559 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1982EMA not concerned about the same manufacturing facility? finance.yahoo.comMiljenko Zuanic-12/8/2016
1981First reported results for (MICRO DOSE) bi-specific REGN1979 in NHL/CLL. Toxic Miljenko Zuanic-12/5/2016
1980And I like this picture, professional manufacturing facility. timesunion.comMiljenko Zuanic-12/2/2016
1979businessinsider.com "Kjuka mu je uvik carvena!"Miljenko Zuanic-12/2/2016
1978For ones I agree (not that my opinion meter, anyway) with Schleifer: bloomberg.Miljenko Zuanic-12/1/2016
1977RG7716 is Eylea real trat (IMO), not Fovista. ncbi.nlm.nih.gov Ask Yan for opiMiljenko Zuanic-12/1/2016
1976If you want both drug to act locally, than bispecif may not be a bad idea??!!Miljenko Zuanic-12/1/2016
1975I believe REGN CSO has stated the real benefits if bispecifics are bringing two Felix B-11/30/2016
1974Few more details....fascinating how mediocre is sanofi relation with FDA-inspectMiljenko Zuanic111/30/2016
1973Following Roche steps with Ang2-VEGF bi-specific: fiercebiotech.com MedImmune aMiljenko Zuanic-11/29/2016
1972Based on this Leering report, it seams that was facility problems at most, DepenMiljenko Zuanic-11/24/2016
1971I SHOULD STOP MAKING SPECULATIVE PROJECTION: finance.yahoo.comMiljenko Zuanic-11/17/2016
1970Why now this trial: Evaluating Effect of the Study Drug Praluent (Alirocumab) onMiljenko Zuanic-11/15/2016
1969RE:CVOT by Nov.-end? Have no idea how much will stock correct IF there is no inMiljenko Zuanic-11/14/2016
1968finance.yahoo.com Table and chart for January-17.Miljenko Zuanic-11/10/2016
1967I am somewhat new to the world of investing but where do you get this: "SoFelix B-11/10/2016
1966Hi Jim, "pain" is your field, and I know slim to nothing about. We (meMiljenko Zuanic-11/10/2016
1965A few random thoughts, following up on your post. 1) As you know, I was skepBiotech Jim-11/9/2016
1964<<I would make speculative projection (not typical for me): Fasinumab willMiljenko Zuanic-11/9/2016
1963Leo: (at CC) <It is only been a week since we received the complete response Miljenko Zuanic-11/4/2016
1962Praluent: Maybe, there is bit of hope (light at the end of tunnel), circ.ahajouMiljenko Zuanic-11/3/2016
1961Bastards in France continuously got 483, and they did WHAT? Stupid Regeneron! fMiljenko Zuanic-10/31/2016
1960There in no time frame definition for delay after CRL. It can be few months, it Miljenko Zuanic-10/30/2016
1959Are all CRL 3 months delays?Felix B-10/30/2016
1958THEY HAD 12 FUCKIXX YEARS TO STRAIT-UP MANUFACTURING FOR BIOLOGIC, AND WHAT THEYMiljenko Zuanic-10/29/2016
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News